首页> 外文期刊>Allergy and asthma proceedings >Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria.
【24h】

Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal allergic rhinitis and chronic urticaria.

机译:儿科人群中的抗组胺药:治疗季节性变应性鼻炎和慢性荨麻疹时可达到最佳效果。

获取原文
获取原文并翻译 | 示例
           

摘要

Antihistamines are used frequently in adult and pediatric patients as first-line treatment for both allergic rhinitis and urticaria. There are several different antihistamines on the market, generally divided into first- and second-generation products. Although many of these show efficacy, there are significant differences in the side effect profiles of these medications, with resultant differences in their effect on quality of life and other outcomes. Although the most significant differences are between generations, there are considerations even within generations, especially regarding sedation and possible effects on learning. Other than specific situations in which sedation may be a desired effect, the second-generation antihistamines generally are preferred and the risks and benefits of individual drugs within this group need to be considered for each patient's specific circumstances.
机译:抗组胺药在成年和小儿患者中经常用作过敏性鼻炎和荨麻疹的一线治疗。市场上有几种不同的抗组胺药,通常分为第一代和第二代产品。尽管这些药物中的许多药物显示出疗效,但这些药物的副作用方面存在显着差异,因此它们对生活质量和其他结果的影响也存在差异。尽管最显着的差异是几代人之间的差异,但即使是几代人之间也需要考虑,特别是在镇静和对学习的可能影响方面。除了可能需要镇静作用的特定情况外,通常首选第二代抗组胺药,并且需要针对每个患者的特定情况考虑该组中每种药​​物的风险和益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号